CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-24 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 66,681 | ||
| 2026-07-23 | Stout Jay S Chief Technology Officer | Sale | −2,857 | $38.69 | $111K | 205,341 |
| 2026-07-23 | Girao Tiago Chief Financial Officer | Sale | −6,798 | $38.69 | $263K | 240,798 |
| 2026-07-08 | Gloria Melanie Chief Operating Officer | Sale | −1,930 | $39.53 | $76K | 222,463 |
| 2026-07-08 | Gloria Melanie Chief Operating Officer | Sale | −106 | $39.99 | $4K | 222,357 |
| 2026-07-08 | Van Tuyl Christopher Chief Legal Officer | Sale | −1,143 | $39.53 | $45K | 179,454 |
| 2026-07-08 | Van Tuyl Christopher Chief Legal Officer | Sale | −63 | $39.99 | $3K | 179,391 |
| 2026-07-08 | Stout Jay S Chief Technology Officer | Sale | −1,906 | $39.53 | $75K | 209,779 |
| 2026-07-08 | Stout Jay S Chief Technology Officer | Sale | −105 | $39.99 | $4K | 209,674 |
| 2026-07-08 | Stout Jay S Chief Technology Officer | Sale | −1,399 | $39.53 | $55K | 208,275 |
| 2026-07-08 | Stout Jay S Chief Technology Officer | Sale | −77 | $39.99 | $3K | 208,198 |
| 2026-07-02 | Venker Eric Chief Executive Officer | Sale | −3,092 | $38.48 | $119K | 254,280 |
| 2026-07-01 | Venker Eric Chief Executive Officer | Option exercise | +92,188 | $14.46 | $1.3M | 344,001 |
| 2026-07-01 | Venker Eric Chief Executive Officer | Returned to the company | −86,629 | $38.14 | $3.3M | 257,372 |
| 2026-07-01 | Venker Eric Chief Executive Officer | Option exercise · Capped Value Appreciation Rights | −92,188 | 1,014,062 | ||
| 2026-06-26 | Gloria Melanie Chief Operating Officer | Sale | −14,748 | $38.18 | $563K | 227,359 |
| 2026-06-26 | Gloria Melanie Chief Operating Officer | Sale | −2,966 | $38.95 | $116K | 224,393 |
| 2026-06-26 | Stout Jay S Chief Technology Officer | Sale | −33,277 | $38.18 | $1.3M | 218,408 |
| 2026-06-26 | Stout Jay S Chief Technology Officer | Sale | −6,723 | $38.94 | $262K | 211,685 |
| 2026-06-26 | Van Tuyl Christopher Chief Legal Officer | Option exercise | +17,824 | $15.20 | $271K | 198,421 |
Page 2 of 10 · 191 trades